scispace - formally typeset
S

Seon Hee Chang

Researcher at University of Texas MD Anderson Cancer Center

Publications -  50
Citations -  14018

Seon Hee Chang is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cytokine & Immune system. The author has an hindex of 35, co-authored 47 publications receiving 12760 citations.

Papers
More filters
Journal ArticleDOI

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

TL;DR: In vivo, antibody to IL- 17 inhibited chemokine expression in the brain during experimental autoimmune encephalomyelitis, whereas overexpression of IL-17 in lung epithelium caused Chemokine production and leukocyte infiltration, indicating a unique T helper lineage that regulates tissue inflammation.
Journal ArticleDOI

Stat3 regulates cytokine-mediated generation of inflammatory helper t cells

TL;DR: A pathway whereby cytokines regulate THi differentiation through a selective STAT transcription factor that functions to regulate lineage-specific gene expression is demonstrated.
Journal ArticleDOI

Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling

TL;DR: It is shown that interleukin-1 (IL-1) signaling on T cells is critically required for the early programming of Th 17 cell lineage and Th17 cell-mediated autoimmunity and this pathway may serve as a unique target for Th17cell-mediated immunopathology.
Journal ArticleDOI

Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs

TL;DR: It is found that the development of Th17 and Foxp3(+) Treg cells was associated in immune responses and molecular antagonism and plasticity of Treg and Th17 cell programs are demonstrated.
Journal ArticleDOI

Regulation of inflammatory responses by IL-17F.

TL;DR: IL-17F is an important regulator of inflammatory responses that seems to function differently than IL-17 in immune responses and diseases, and this requires IL- 17 receptor A, tumor necrosis factor receptor–associated factor 6, and Act1.